ARCHIVES

Ethicists dispute von Eschenbach’s claim that his NCI-FDA conflicts are managed. NCI-FDA chief appears to cite Klausner-era “in-box rule.”

This article is from The Cancer Letter archive.

Vol. 31 No. 46 | December 16, 2005

Download PDF Visit The Full Archive

Related Articles

President’s Cancer Panel Road Show Producers Ideas For Improving Finding Mechanisms; NCI Buys Some

July 23, 1982

Cancer Groups Criticize FDA For Ignoring Expert Advice.

November 24, 2000

Carbone Names NCI Clinical Director, Rauscher shuffles Treatment Activities

August 30, 1974

VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial

May 30, 2014

In Brief: George Santos Wins Bristol-Meyers Award; SG Elects William Creasman President; Levin To MDA

April 1, 1988

How to Become a Urology Millionaire…Alas, One Little Problem—Overtreatment

April 13, 2012